Aripiprazole in Late Life Bipolar Disorder

NCT00194038 ↗

Phase 4 Completed 20 enrolled University Hospitals Cleveland Medical Center Bristol-Myers Squibb · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to analyze the effectiveness and tolerability of a new medication, aripiprazole (Abilify), in individuals age 50 years and older who have bipolar disorder (manic-depressive illness).

Timeline

Start: 2004-04
Primary completion: 2006-06
Completion: 2006-06

Publications

Results Sajatovic M, Coconcea N, Ignacio RV, Blow FC, Hays RW, Cassidy KA, Meyer WJ. Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial. J Clin Psychiatry. 2008 Jan;69(1):41-6. doi: 10.4088/jcp.v69n0106.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Aripiprazole	Other / unclassified	5 mg	—

Aripiprazole in Late Life Bipolar Disorder

Summary

Timeline

Publications

Drugs

Indications